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Allogeneic effect  factor  (AEF) 1 is  a  soluble  mediator secreted  into  supernates  of 
short-term secondary mixed lymphocyte cultures (MLC) of in vivo alloantigen-primed 
T  cells  (1-7).  Although  studied  and characterized  initially in  terms of its ability to 
activate  B  cells  to  develop  antibody  responses  in  vitro  to  particulate  and  soluble 
antigens in the absence of helper T  cells (1-7), recent studies in our laboratory have 
focused on some very interesting  T  cell-activating properties of AEF  (8-13).  These 
latter studies have shown that AEF (a)  is highly mitogenic for unprimed T  cells,  (b) 
can  trigger  the  differentiation  of unprimed  T  cells,  in  the  absence  of exogenous 
antigen,  into cytotoxic T  lymphocytes (CTL), which  display the Lyt-2  ÷ phenotype, 
preferentially  lyse  H-2-identical  target  cells,  and  are  directed  against  antigen(s) 
determined by the K region of the murine major histocompatibility complex, and (c) 
stimulates the differentiation of unprimed T  cells into responding cells of the Lyt-1 ÷ 
phenotype  that  can  be  restimulated  in  secondary  syngeneic  mixed  lymphocyte 
reactions  (MLR)  that  are directed  against  antigen(s)  determined by the I  region of 
the H-2 complex (8-13). These latter properties of AEF, namely its ability to trigger 
differentiation  of unprimed  T  cells  into  functional  effector cells,  distinguishes  this 
biologically active mediator from those  lymphokines, such  as T  cell growth  factor, 
that are now designated interleukin-2  (IL-2); IL-2 moieties are characterized biolog- 
ically  by  their  ability  to  support  long-term  growth  of  primed,  fully  mature  T 
lymphocytes previously activated by antigen or otherwise (14). 
This  heterogeneity  of  biological  activities  displayed  by  AEF-containing  MLC 
supernates  raises  the  question  of whether  the same or different  molecules  mediate 
these various effects. Recent biochemical analysis has shown that the AEF-mediated 
B cell- and T  cell-activating properties cochromatograph on sizing gels and coelectro- 
phorese when subjected to isoelectric focusing (D. H. Katz and A. Altman. Manuscript 
in preparation.).  Although  suggestive, such  biochemical criteria are still  inadequate 
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to allow conclusions concerning molecular heterogeneity or homogeneity with regard 
to the distinct biological activities of AEF. In order to address this and other questions 
more  directly, and  to provide a  more  uniform  source of AEF molecules for further 
purification and analysis, we have utilized the technique of somatic cell hybridization 
to construct T  cell hybridomas secreting AEF. This report describes the characteristics 
of such hybridomas and the AEF secreted by them. 
Materials  and  Methods 
Mice.  All inbred mice employed in these studies were obtained from the Scripps Clinic and 
Research Foundation (SCRF) mouse breeding colony, The Jackson Laboratory (Bar Harbor, 
Maine), or from Simonsen Laboratories (Gilroy, Calif.). 
Preparation ofsAEF.  AEF was prepared in the conventional manner as described previously 
(1, 9).  1 ×  10  thymoeytes from young (4- to 6-wk-old) DBA/2 donors were mixed with an 
equal  number  of irradiated  (1,500  tad)  spleen cells from  (C3H  ×  DBA/2)  F1  hybrid mice 
(C3D2F1)  and  injected intravenously into  irradiated (650  rad)  DBA/2  recipient mice.  The 
alloantigen-activated T  cells recovered from the spleens of these mice 7 d later were co-cultured 
with  fresh  irradiated C3D2FI  stimulator spleen cells.  Responder  and  stimulator cells were 
pretreated  with  10  p.g/ml  phenylmethyisulphonyl fluoride  to  inhibit  the  activity of serine 
proteases that tend to degrade AEF (6) and cultured for 18-24 h at  1 x  107/ml each in serum- 
free RPMI-1640  medium  (Grand Island Biological Co., Grand Island, N. Y.) supplemented 
with 1 ×  10  -4 M 2-mercaptoethanol. Cultures were maintained in a Mishell-Dutton gas mixture 
on a  rocking platform. The culture supernate was obtained by centrifugation (2,500  rpm,  15 
rain), filter sterilized, and stored at -70°C until used. 
Construction of AEF-secreting Hybridomas.  T  cell blasts activated to alloantigen in vivo and 
secondarily stimulated in vitro as described above were recovered after  18 h  in culture and 
separated in FicolI-Hypaque in Dulbecco's minimum essential medium (DMEM): phosphate- 
buffered saline solution prepared as described elsewhere (15). Cells recovered from the interface 
after eentrifugation were predominantly blastlike in nature and were used for hybridization. 
The  parental cell line used for hybridization was the AKR-derived T  cell line, BW 5147 
obtained from Dr. Robert Hyman of The Salk Institute, La Jolla, Calif. This line is hypoxan- 
thine  guanine  phosphoribosyl transferase  negative,  and  displays the  following cell  surface 
phenotype (16): H-2 k÷, Thy-l.1 +, Ig-, Ia-, Lyt-I  +, Lyt-2-. 
Cell fusion was performed according to Gefter et al. (17) with some modifications. Parental 
tumor cells were washed twice in DMEM, and 2 ×  106 tumor cells were mixed with  1 X  107 
activated T  cell blasts. The  cell suspension  was centrifuged, and  all medium  was carefully 
removed by aspiration. The cell pellet was then  resuspended in 0.2 ml of 30%  polyethylene 
glycol 1,000 in DMEM. Cells remained in this solution for a total of 8 min, during which time 
they were centrifuged for 6 rain at  1,000 rpm (ambient temperature). At the end of 8 min, 5 ml 
of DMEM was added to the tube, and the cells were washed twice in this medium. They were 
resuspended in DMEM supplemented with 10% fetal calf  serum (FCS) and incubated overnight 
at 37°C in a  10% CO2 in air atmosphere. The next day, the cells were pelleted by centrifugation 
and resuspended in 30 ml of FCS-supplemented DMEM containing hypoxanthine (1  ×  10  -4 
M),  aminopterin  (4  ×  10  -6 M), and  thymidine (1.6  ×  10  -5 M),  and  were distributed into 
individual wells of 96-well flat-bottom microplates. Cultures were fed after 1 wk by the addition 
of one drop of this same medium without aminopterin. 
Screening of hybridoma supernates was carried out by incorporating multiple dilutions of 
each  given supernate  tested into primary in  vitro antibody responses to sheep erythrocytes 
(SRBC) or trinitrophenyl (TNP)-derivatized SRBC (see below). 
Biological Assays  for AEF Activity 
tN  VITRO ANTmOOV RESPONSE SYSTEm.  AEF preparations and  hybridoma supernates were 
tested for their ability to reconstitute primary in vitro antibody responses against SRBC or 
TNP-SRBC of anti-Thy  1.2 serum plus complement  (C)-treated DBA/2 or A/J spleen cells. 
The  methods for establishing such cultures and  for analyzing the resulting SRBC- or TNP- 
specific plaque-forming cells (PFC) were identical with those described previously (1). 958  ALLOGENEIC  EFFECT FACTOR-SECRETING T  CELL HYBRIDOMAS 
CTL CULTURE  SYSTEM.  Spleen cell suspensions of normal, unprimed mice were prepared and 
depleted  of erythrocytes by NH4CL treatment  as  described  previously  (9). The cells  were 
resuspended in Eagle-Hank's amino acid (EHAA) medium (18) supplemented with 5 ×  10  -5 M 
2-ME and 5% heat-inactivated FCS and cultured in Cluster  ~  tissue culture plates (Microbio- 
logical Associates, Waikersville,  Md.) at 7.5 X 106 ceils per well in 2 ml of medium containing 
various concentrations of AEF or hybridoma supernate as described in Results.  The cultures 
were maintained for 5 d in a 5% CO2 incubator and then assayed for their cytolytic activity. 
The  cytolytic  activities  in  such  cultures  were  determined  using  the  Thy-56  lymphoma 
(BALB/c, H-2 d) labeled with 5XCr as described in detail elsewhere  (19). 
PROLIVERATION ASSAY.  2.5-5  ×  105 spleen  cells were cultured  in triplicate in flat-bottom 
wells of Microtest II tissue culture plates (Falcon Labware, Div. of Beeton, Dickinson & Co., 
Oxnard, Calif.)  in  0.2 ml of complete EHAA medium containing various concentrations of 
AEF or hybridoma supernate. Cultures were maintained for 5 d, pulsed for the final 16 h with 
1 #Ci tritiated thymidine [3H]TdR, New England Nuclear, Boston, Mass.),  and harvested on 
a cell harvester (Skatron A.S. Lierbyen, Norway) (20). 
Antisera and  Cytolytic Depletion.  Anti-Thy-l.l  and  Thy-l.2  antibodies  were  prepared  as 
described in detail previously (21). A.TL anti A.TH (anti-Ia  8) and B 10.A anti-B 10 (anti-l-A d) 
were  prepared  as previously described  (13). A  similar immunization  reffimen  was  used  to 
prepare B10.BR anti-Bl0.D2 (anti-H-2 a) and BI0 anti-B10.BR (anti-H-2) antibodies. All of 
these reagents had titers of 1:1,000 or higher in a C-dependent microcytotoxicity assay (22). 
Analysis  of cell  surface  phenotypes  of hybridomas  was  carried  out  in  a  C-dependent 
microcytotoxicity assay previously described from this laboratory (22). 
Results 
AEF-secreting  T  Cell Hybridomas Replace Helper  T  Cells in Prima~y In  Vitro Anti-SRBC 
Responses of DBA/2 B  Cell Suspensions.  After fusion, hybrids were detected in  115 of 
288 wells plated, and the supernates from these positive wells were screened for B cell- 
activating capacities. Approximately one-half of these supernates manifested little or 
no positive biological effects, about  one-third  displayed  low-to-moderate biological 
activity,  and  a  small  number  demonstrated  rather  potent  biological  effects when 
tested, as shown below. 
The  experiment  portrayed  in  Fig.  1 illustrates  the  activities  of two  high  AEF- 
secreting hybridomas in terms of their B cell-activating properties.  In the left panel 
are shown the good in vitro responses of untreated DBA/2 spleen cells to SRBC and 
the abrogation of such responses after treatment of such cells with anti-Thy-l.2 plus 
C. In the right panel, the vertical bar illustrates the capacity of a  conventional AEF 
preparation to restore totally the responses of T  cell-depleted B cells after stimulation 
with  SRBC.  In  addition,  the  B  cell-activating effects of five  different  hybridoma 
supernates, tested at three different concentrations each, are illustrated. The hybrid- 
oma supernates tested were obtained in serum-free conditions by washing the cultured 
hybridoma cells,  replating them  in  serum-free medium, and  harvesting the culture 
supernates after 24 h. It is clear that supernates from those hybridomas designated 27 
and  34  display  strong  B  cell-activating effects,  which  dilute  out  in  a  dose-related 
fashion. Supernate  from the hybridoma designated hybridoma  18 displayed modest 
B cell-activating effects only at the highest concentration  tested, whereas supernates 
from  hybridomas  31  and  10  are  negative  for such  activity.  Although  not  shown, 
culture supernates from the unfused parental line, BW 5147, likewise failed to display 
any B cell-activating properties in these cultures. Hybridomas 27 and 34 were selected 
for further  experimentation  and  have now  been  maintained  in  culture  for  ~ 1 yr, 
retaining their biological activity. 
Surface Phenotype Analysis  of AEF-secreting Hybridomas.  Hybridomas 27 and 34 were KATZ,  BECHTOLD,  AND  ALTMAN 
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Fro.  I.  AEF-secreting T  cell hybridomas (Hyb)  replace helper T  cells in primary in  vitro anti- 
SRBC responses of DBA/2 cell suspensions. DBA/2 spleen cells, either untreated (1.0 X  10  ~ cells/ 
well) or depleted of T  cells by previous treatment with anti-0 serum plus C  (0.5 X  106 cells/well) 
were cultured for 5 d in the presence of stimulating SRBC either without AEF added to the euhure 
(left  panel)  or  together with  either conventional  AEF or  potential  AEF-eontaining hybridoma 
supernates at the concentrations indicated (right panel). The data are presented as SRBC-specific 
IgM PFC/107 cells determined from triplicate cultures of each type. Control cultures consisting of 
either untreated or T  cell-depleted spleen cells cultured in the absence of any stimulating SRBC 
yielded PFC levels ranging from 0 to 45 irrespective of whether AEF or AEF-containing hybridoma 
supernates were present in such cultures. 
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analyzed for expression ofThy- 1 and H-2 markers in a C-dependent microcytotoxicity 
assay. The results of such analyses demonstrated clearly that these are both somatic 
cell hybrids as evidenced by their expression of antigens encoded by both Thy-1 alleles 
and the H-2 antigens characteristic of each of the respective partner cells fused. 
Biological  Effects  on  B  and  T  Lymphocytes  of AEF Hybridoma  Supernate  Obtained  After 
Alloantigen  Restimulation.  Because  the  AEF  hybridomas were  derived  from  T  cell 
blasts generated after stimulation by alloantigens, we were interested in determining 
whether the hybridomas themselves displayed any responsiveness to additional stim- 
ulation  with  the  original  inducing alloantigen. Thus,  cells of hybridoma 34  were 
cultured overnight in  the presence of equal  numbers of irradiated C3D2Fz  target 
spleen cells, and the supernate was recovered from such stimulated hybridoma cultures 
and analyzed for biological activities on both B and T  lymphocytes. 
As shown in Fig. 2, the supernate from such restimulated hybridoma cells displayed 
excellent  B cell-reconstituting effects in in vitro antibody responses  to TNP-SRBC 
(left panel), and perfectly clear T cell-activating properties as manifested by its ability 
to stimulate development of CTL in the absence of exogenous antigen (middle panel), 
and direct proliferation of unprimed T  lymphocytes (right panel). It should be noted 
that these activities were obtained with a concentration of hybridoma supernate (1: 
20)  that is well below the activity threshold of supernates from the same hybridoma 
not restimulated with alloantigen (see also Fig.  1).  Furthermore, it should be noted 
that the culture supernate of the unstimulated hybridoma failed to display B cell- or 
T  cell-activating properties in this experiment when tested at the same dilution. 
To  ascertain  whether  the enhanced  biological  activity displayed by the  culture 
supernate of the C3D2Ft-stimulated hybridoma reflects an antigen-specific event, we 960  ALLOGENEIC EFFECT  FACTOR-SECRETING  T  CELL  IIYBRIDOMAS 
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Fie.  2.  Biological  effects on B and T lymphocytes of AEF hybridoma (Hyb) supernate obtained 
after alloantigen restimulation. AEF:Ilyb 34 was cultured  for 24 h in the presence of an equal 
number of fresh, irradiated (1,500 rad) C3D2FI stimulator cells. The supernate recovered from such 
stimulated hybridoma cultures was tested at  a final dilution of 1:20 for its B cell- and T cell- 
activating properties. B cell-activating properties were measured in terms of capacity to stimulate 
T cell-depleted DBA/2 spleen cells to respond in vitro to TNP-SRBC. The data are shown in the 
far left panel as TNP-specific IgM PFC/107 cells; control cultures of the same cells stimulated with 
TNP-SRBC in the absence of Ityb 34 supernate yielded no detectable TNP-specific PFC. The T 
cell-activating properties of AEF:}lyb 34 supernate at this dilution were measured by stimulation 
of self-specific  CTL (middle panel) and direct mitogenic activity on unprimed T lymphocytes (right 
panel), using assay systems as  described in  Materials and  Methods. The  mitogenic activity is 
expressed as  net  counts  per  minute  per  culture  in experimental cultures after subtraction  of 
background counts per minute in unstimulated cultures. Background levels for CTL and mitogenic 
activities, were 6.9% lysis and 5,000 cpm, respectively. 
Supernates from AEF:Hyb 34 cells not subjected to alloantigen restimulation failed to display 
significant biological activities at a final dilution of 1:20. 
performed the following experiment: cells of hybridomas 27 and 34 were cultured for 
24 h  in the absence or presence of 4 ×  10  ~ irradiated spleen cells of either the specific 
(H-2 k)  or an unrelated (H-2 b)  target  haplotype and their level of [3H]TdR uptake 
was measured after a  4-h terminal pulse. Despite the high level of spontaneous [3H]- 
TdR  uptake by the unstimulated hybridoma cells, a  specific alloantigen-dependent 
stimulation could readily be observed.  Thus, the net stimulation of hybridomas 27 
and 34 was 21,971  and  17,897 cpm, respectively, by specific CBA (H-2 k)  stimulator 
cells and only 5,132 and 3,351  cpm, respectively, by the unrelated C57BL/6 (H-2 b) 
stimulator cells. This reflects a  4.2- to  5.3-fold difference in net stimulation by the 
specific vs. the unrelated spleen cell targets. 
Inhibition of B Cell-activating Properties of AEF Hybridoma Supernate by Anti-Ia Antibod- 
ies.  One of the prominent distinguishing features of AEF, as compared with many 
other nonspecific lymphokines, is the fact that determinants encoded by genes of the 
I region of the H-2 complex are present on the biologically active AEF molecules (2). 
In order to verify that the AEF molecules detected in the T  cell hybridoma supernates 
presented in this study were likewise Ia-positive, we investigated whether the activity 
of such molecules would be sensitive to the effects of anti-Ia antibodies. 
The experiment summarized in Fig. 3  demonstrates that  this is, indeed, the case. 
Anti-Thy-l.2-serum-treated spleen cells of A/J  mice were used as responder cells in 
this experiment because they are  totally disparate at  the I  region from  the  DBA/2 
strain  of  origin  of  the  AEF-secreting hybridomas.  Moreover,  A/J  mice  are  H-2 
identical with the B 10.A mice used for preparation of the anti-/-A  a serum employed, KATZ, BECttTOLD,  AND ALTMAN  961 
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FIG. 3.  Inhibition of B cell-activating properties of AEF hybridoma (Hyb) supernate  by anti-LA d 
antibodies.  Unprimed A/J spleen cells depleted of T lymphocytes by treatment with anti-0 serum 
plus C were cultured (0.5 ×  10  ~ cells/well) for 5 d in the presence of TNP-SRBC as stimulating 
antigen  and either conventional  AEF (final concentration  1:40, panel A) or supernate  from AEF: 
ltyb 34  (final concentration  1:5, panel  B). Cultures  contained either no inhibitor serum, normal 
mouse serum,  anti-Ia  '~, or anti-l-A a serum  at  the  final  concentrations  indicated.  The data are 
presented as TNP-specific IgM PFC/107 cells assayed in triplicate cultures of each type. Control 
cultures of T cell-depleted A/J spleen cells cultured in the presence of TNP-SRBC but without any 
source of AEF yielded no detectable TNP-specific PFC response. Other control cultures of untreated 
A/J spleen cells produced 516 TNP-specific PFC in response to TNP-SRBC, and this response was 
not inhibited in the presence of anti-l-A a serum. 
and this serum  was devoid of any reactivity with A/J  spleen cells in a  C-dependent 
microcytotoxicity assay (not shown). 
As shown in panel A, cultures of such T  cell-depleted A/J spleen cells exposed to a 
conventional AEF preparation develop good primary TNP-specific in vitro responses 
to TNP-SRBC.  Incorporation of anti-Ia  s antibodies has no effect on  the capacity of 
this AEF preparation (also derived from DBA/2-activated T  cells) in stimulating such 
B cell responses. In contrast, incorporation of antibodies specific for I-A a determinants 
substantially inhibits the activity of this  AEF preparation  on  the A/J  responder  B 
cells. 
As shown  in panel B, AEF activity of serum-free supernate of hybridoma 34 is not 
significantly affected  by the incorporation of normal  mouse serum  of B 10.A origin, 
whereas  incorporation  of  anti-I-A a  antibodies  at  the  same  concentration  totally 
abolishes the  B  cell-activating properties of this AEF-secreting hybridoma.  Control 
cultures of untreated (i.e., T  cell-containing) A/J spleen cells developed good responses 
to TNP-SRBC,  and  these  responses were  not  inhibited by the same  anti-I-A a  anti- 
bodies (Fig. 3, legend). 
Cloning  of Hybridorna  34.  Hybridoma  34  was cloned by plating an  average of 0.8 
hybridoma  cells per  fiat-bottom  microtiter well  (200  ~1)  in  the  presence  of heavily 
irradiated BALB/c  thymocytes, which  served as feeder cells. Growth  of hybridoma 
cells was detected in  75% of the wells after  10-14 d, and, of these, about  two-thirds 
contained single cell clones. These clones were transferred to  16-mm  wells, grown to 962  ALLOGENEIC  EFFECT  FACTOR-SECRETING  T  CELL  HYBRIDOMAS 
confluence, and their supernates were tested for induction of self-reactive CTL at a  1  : 
10  final  dilution.  About  30%  of the  supernates  displayed  biological  activity  as 
evidenced by the  resultant  CTL activity, which  was  significantly above the  back- 
ground level of 51Cr release. Furthermore, the culture supernates derived from some 
of these clones were mitogenic for peanut  agglutinin-nonagglutinable  (PNA-)  thy- 
mocytes, indicating  that  the  hybridoma-derived AEF  is  indeed  mitogenic  for un- 
primed T  cells. Thus, whereas the level of [aH]TdR uptake by 2 ×  10  -5 unstimulated 
PNA- thymocytes in a 5-d assay was 171 cpm, stimulation by the supernate of one of 
the clones was 3,247 and  14,716 cpm at  1:20 and  1:10 dilutions, respectively. 
Cell  Sorter  Analysis  of Ia  Determinants  on  AEF-secreting  Hybridomas.  In  view  of our 
findings  that  conventionally derived AEF  bears  Ia  determinants  (2)  and  that  the 
biological activity of both the conventional and the hybridoma-derived AEF prepa- 
rations is inhibited by specific anti-Ia antibodies, it was of importance to determine 
whether the hybridoma cells express Ia antigens of the normal T  cell partner, i.e., Iad. 
Thus,  parental  and  cloned  hybridoma cells  were  incubated  with  B10.A  anti-B10 
(anti-Ia  d)  or A.TL anti-A.TH  (anti-Ia  8) sera, stained with a  fluorescent rabbit anti- 
mouse  Ig serum,  and  subjected  to  analysis on a  cell sorter  (FACS  II;  B  D  FACS 
Systems, Mountain View, Calif.) (Table I). The intensity of fluorescence by the anti- 
Iad-treated cells was significantly higher than that by the anti-IaS-treated ones for the 
[,arental hybridoma 34 cells and for two of its clones (34.1  and 34.2), whereas another 
cane (34.3)  did not display a specific fluorescence pattern. These results indicate that 
at least some of the hybridoma cells express Ia determinants. 
Discussion 
The technique of somatic cell hybridization as refined by KiJhler and Milstein for 
immunologically relevant cells (23), has provided a  revolutionary tool for studies on 
lymphocyte  biology.  This  technology,  developed  initially  for  the  construction  of 
hybrid cell lines of the B cell lineage, subsequently was extended to the construction 
of T  cell hybridomas by fusion of either normal or activated T  cells with established 
T  lymphoma lines  (16,  24,  25).  Although  the success of hybridization with such T 
TABLE I 
FACS-H Analysis of la Determinants on an AEF-secreting Hybridoma and its 
Cloned Cell Lines 
Cells 
Cells in fluorescence channels 200-1,000 
Anti-Ia  ~  Anti-la  d  A 
% of total cells 
Hybridoma 34  49.9  70.7  20.8 
Clone 34.1  14.4  44. I  29.7 
Clone 34.2  46.4  73.3  26.9 
Clone 34.3  56.9  59.3  2.4 
Cells  (5 ×  10n/ml)  were incubated in the cold with 200 #1 of a  1  : 10 dilution of 
either BI0.A anti-B10  (anti-la  a) or A.TL anti-A.Ttt  (anti-Ia  ~) sera followed 
by  200/d  of a  1:100  dilution  of a  fluorescein-conjugated rabbit  anti-mouse 
immunoglobulin (30 min each), washed three times, and analyzed on the cell 
sorter (FACS II; Becton, Dickinson & Co). The FACS II was calibrated  using 
5-/.tm latex microspheres (light scatter peak at channel 225;  fluorescence peak 
at channel 250). KATZ, BECHTOLD, AND ALTMAN  963 
lymphoma lines was verified by appropriate codominant expression of certain cell 
surface markers characteristic of the phenotypes of each of the respective partner cells, 
these early studies failed to demonstrate, where analyzed, expression of functional T 
cell characteristics (16, 24, 25). Subsequently, several laboratories have been successful 
in constructing T  cell hybridomas expressing T  cell function of the nonlymphoma 
partner as manifested by the active secretion of soluble mediators capable of exerting 
immunoregulatory effects (26-33);  with one exception (27),  these successful fusions 
have  utilized the AKR T  lymphoma line designated BW5147.  All of these  latter 
studies have been concerned with the construction ofT cell hybridomas producing T 
cell  factors capable  of suppressing  immune responses  either in  an  antigen-specific 
manner for humoral responses  (26,  27,  29-31)  or delayed-type hypersensitivity re- 
sponses  (32),  or  in  an  antigen  nonspecific manner  for humoral  responses  (33)  or 
selective for antibody responses of the IgE class (28). 
A recent report  (34)  described the construction of a  T  hybridoma line capable of 
secreting  biologically active  factors  effective in  stimulating hematopoietic  colony 
growth and B cell responses in vitro; however, this line did not secrete such factors 
spontaneously and required stimulation by concanavalin A to release active molecules 
into culture supernates. The present report constitutes, therefore, the first description 
of the successful construction of hybrid T  cell lines spontaneously secreting a biolog- 
ically active factor capable of enhancing immune responses, namely AEF. 
The  construction of AEF-secreting hybridomas was  accomplished by  fusing the 
BW5147 cell line with alloantigen-activated T  cell blasts obtained after consecutive 
in vivo and in vitro activation steps. T  cell blasts obtained in this manner yielded a 
relatively high  fusion frequency with about  one-third of such  hybrids manifesting 
some degree of AEF-like biological activity. Two of the hybridomas secreting rather 
substantial  quantities of AEF were chosen for the analyses presented herein. That 
these two lines secreting AEF, are indeed, true hybrids was verified by demonstrating 
codominant  expression  of the  relevant  allelic  forms  of Thy-1  antigens  and  the 
serological determinants of H-2 contributed by each of the respective fused partner 
cells. 
The supernates obtained from hybridomas 27 and 34 displayed typical functional 
characteristics ascribed to AEF. Thus, these hybridoma supernates were capable of 
activating B lymphocytes to respond to either SRBC or TNP-SRBC in cultures de- 
pleted of helper T  lymphocytes normally required for such responses. Moreover, the 
typical T  cell-activating properties of AEF, as described in recent studies from this 
laboratory (8-13), such as the ability to stimulate autonomous development of self- 
specific CTL and the capacity to directly stimulate T cell proliferation, were likewise 
present in these hybridoma supernates. The fact that the biological activities of AEF 
on  both  B and T  lymphocyte targets coexisted in  the same hybridoma supernates 
suggests, but does not prove, that these two distinct activities may be mediated by the 
same molecule; definitive proof on this issue must await complete cloning of these 
hybridoma lines and  isolation to homogeneity of the active molecules secreted by 
them. 
Evidence supporting the fact that the activities observed were, indeed, mediated by 
AEF, and not by one or more artifactual components of the cultured lines, can be 
summarized as follows:  (a)  supernates obtained  for testing in the biological assays 
performed were free of all exogenous serum and/or protein constituents; (b) supernates 964  ALLOGENEIC  EFFECT FACTOR-SECRETING T  CELL ttYBRIDOMAS 
from  the  parent  thymoma  line cultured  alone,  as  well  as  from  numerous  hybrids 
constructed from the same starting  cell population,  were devoid of any detectable 
AEF activity (moreover, such  negative supernates were unable to suppress  positive 
AEF-mediated biological effects, not shown); and (c) the AEF activities displayed by 
positive hybridomas, like those same activities exhibited by conventional preparations 
of AEF, could be abrogated by exposure to specific anti-Ia antibodies, thus verifying 
the expression of Ia determinants on the relevant molecules. It is interesting in the 
latter regard that most of the functional T cell hybridomas that have been successfully 
constructed,  including  those  reported  here,  are  lines  capable  of producing soluble 
mediators that bear I region determinants. 
Another new  finding described in the  present  report is the ability of these AEF- 
secreting hybridoma lines to respond to specific alloantigen stimulation. Responsive- 
ness was verified by induced proliferation of hybridoma 34 after reexposure to fresh, 
irradiated  C3D2F1  target  cells many  months  after initial  fusion. This  proliferative 
burst was accompanied by secretion of significantly increased quantities of AEF into 
supernates of such stimulated cultures, effective in exerting both B cell- and T  cell- 
activating effects at a dilution factor well below detectable activities in supernates of 
unstimulated cultures of the same line. This contrasts with the failure of K6hler et al. 
(25)  to observe either specific responsiveness or production of AEF  in  hybridomas 
constructed from MLR-stimulated T  cells and the same BW5147 thymoma line. The 
differences between their results and ours reported here most likely relate to the degree 
of T  cell activation  used  in  obtaining  the blasts  for fusion.  In  their study, T  cells 
obtained  from  primary  MLR  activation  were  employed,  whereas  in  the  present 
studies we utilized T  cell blasts activated by consecutive in vivo and in vitro stages. 
Whereas our hybridoma is functionally responsive to specific antigen stimulation as 
evidenced  by  proliferation  and  increased  secretion  of AEF,  it  has  not  yet  been 
determined whether our lines possess  any specific cytolytic activities. 
In  addition  to  the  results  presented  here,  studies  currently being  conducted  in 
collaboration with W. H. Fridman and colleagues have shown that both hybridomas 
27 and 34 express Fc receptors (FcR) specific for immunoglobulins of the IgG class 
(FcRy)  (W. H. Fridman, et al. Manuscript  in preparation.). Moreover, like a T  cell 
hybridoma constructed by these same investigators that  is also FcRy positive (33), 
both hybridoma 27 and 34 secrete immunoglobulin-binding factor (IBF) activity (35- 
37), and their line (designated T2D4) appears to secrete AEF-like enhancing activity. 
It should be emphasized, however, that preferential expression of either AEF-enhanc- 
ing  or  IBF-suppressive  activities  by  the  T2D4  and  our  hybridoma  lines  depends 
critically on the culture conditions used for the preparation of the biologically active 
supernates.  Although exerting opposite, suppressive activity on T  cell-dependent in 
vitro antibody responses, IBF, like AEF, has recently been found to bear Ia determi- 
nants  (37). Details of these studies will be published elsewhere in the near future. It 
is  interesting to find these  two opposing biological activities, both of which  are Ia 
positive, synthesized and secreted by the same T  cell hybridoma lines, although the 
possible relevance of these findings will not be discussed here. 
It is also worth noting one other point about the AEF-secreting hybridomas 27 and 
34  lines,  namely  that  the  supernate  of both  lines  is  totally  devoid  of detectable 
interferon activity. In  a  recent extensive analysis of the  possible contributions that 
interferon  may  make  to  the  biological  activities  manifested  by  AEF  preparations KATZ, BECItTOLD, AND ALTMAN  965 
obtained  in  the  conventional manner,  we  have shown  that  removal  of interferon 
contaminants  from  AEF  by  hydrophobic  chromatography  does  not  result  in  a 
corollary diminution of AEF activities, but rather tends to increase the expression of 
AEF  effects (20).  The  fact  that  the  AEF-secreting  hybridomas  described  here are 
totally negative for interferon production proves beyond doubt that interferon is not 
responsible for any of the activities ascribed to AEF. 
Finally, it is worth noting that because these T  cell hybridomas secrete Ia-positive 
AEF molecules, our original contention that AEF is indeed derived from T  cells (1, 4- 
6), a position contested somewhat by certain of the results of Delovitch et al. (38, 39), 
has been validated. Biochemical analysis will be undertaken once sufficient quantities 
of the cloned AEF-secreting hybridomas are available. 
These AEF-secreting hybridoma lines,  like others of a  similar  nature,  should  be 
invaluable for allowing future studies on the molecular biology of these important 
immunoregulatory molecules. 
Summary 
T  cell hybridoma lines were constructed by fusion of DBA/2 alloantigen-activated 
T  cell  blasts  with  the  AKR  thymoma  line  BW5147.  Certain  of the  hybridomas 
prepared in this manner secreted spontaneously into their culture supernates biolog- 
ically active molecules that displayed B cell- and T  cell-activating properties charac- 
teristic of allogeneic effect factor (AEF). Cell surface phenotype analysis documented 
that  the hybridomas were, indeed, somatic cell hybrids between the two respective 
partner  cells  used  for fusion.  The  B  cell-activating properties of these  hybridoma 
supernates  was  demonstrated  by their capacity to stimulate  T  cell-depleted spleen 
cells to respond in vitro to T-dependent antigens. The T  cell-activating properties of 
these hybridoma supernates was verified by their capacity to stimulate autonomous 
development of self-specific cytotoxic T  lymphocytes and by their capacity to exert 
mitogenic effects on unprimed T  cells.  The biologically active molecules secreted by 
these hybridomas were, like conventional AEF, inhibitable by specific anti-Ia anti- 
bodies thus  indicating the  presence of Ia determinants on  the  relevant hybridoma 
products. Finally, these AEF-secreting hybridomas could be stimulated to proliferate 
and to secrete increased quantities of AEF when exposed to the specific alloantigen- 
bearing target cells to which the T  cell blasts had been originally sensitized. 
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